Xvivo Perfusion AB (3XV) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ex Vivo Lung Perfusion With Steen Solution™ | Lung Transplantation | Phase I | Completed | Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation | Aug 25, 2010 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ex Vivo Lung Perfusion With Steen Solution™ | Phase I | Lung Transplantation | Completed | Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation | Aug 25, 2010 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Xvivo Perfusion AB (DE:3XV) have in its pipeline
Xvivo Perfusion AB DE:3XV is currently developing the following drugs: Ex Vivo Lung Perfusion With Steen Solution™. These drug candidates are in various stages of clinical development as the company works toward FDA approval.